Abstract
Purpose
In 2020, one million women aged < 55 years were diagnosed with breast cancer globally. The impact of breast cancer and its treatments on these women’s ability to work and need for social benefits may differ by social characteristics. We evaluated social benefit use following breast cancer by education and cohabitation.
Methods
We conducted a nationwide population-based cohort study, including women aged 18–55 years diagnosed with stage I-III breast cancer in Denmark during 2002–2011. Statistics Denmark provided information on cohabitation, education, and social benefit use from 1 year pre-diagnosis to 10 years post-diagnosis. We calculated weekly proportions of self-support, unemployment, disability pension, flexi jobs, and sick leave according to education and cohabitation.
Results
Of 5345 women, 81.8% were self-supporting, 4.5% received disability pensions, 1.6% had flexi jobs, 3.6% were on sick leave, and 5.5% were unemployed 1 year pre-diagnosis. Ten years post-diagnosis, the proportions were 69.0%, 13.0%, 10.5%, 3.4%, and 2.0% of 3663 survivors. Disability pensions and flexi jobs increased from 12.1 to 26.4% and 2.8 to 13.5% in women with short education, from 4.1 to 12.8% and 1.8 to 12.2% in women with medium education, and from 0.8 to 6.0% and 0.9 to 6.9% in longer educated. Disability pensions increased more in women living alone (7.8 to 19.9%), than in cohabiting women (3.6 to 11.3%).
Conclusions
Use of social benefits reflecting lost ability to work was highest in less educated women and in women living alone.
Implications for Cancer Survivors.
Awareness of these groups is crucial when tailoring efforts to support work participation in cancer survivors.
Similar content being viewed by others
Avoid common mistakes on your manuscript.
Introduction
One-third of all incident breast cancers occur in premenopausal women, and the incidence is increasing in high-income countries [1]. These women are expected to have substantial working years left, owing to advanced breast cancer treatments and improved survival. However, work participation is lower in breast cancer survivors than in their cancer-free counterparts [2,3,4,5]. As such, a growing number of breast cancer survivors may lose their ability to work, which is likely to negatively impact their quality of life, mental health, and economy [6, 7].
Premenopausal women tend to have more aggressive tumors and later stage at diagnosis than postmenopausal women. These women are therefore recommended chemotherapy as guideline. Treatment may also include endocrine therapy, radiation therapy, and human epidermal growth factor receptor 2 (HER2) inhibitors. Side effects of these treatments may impact work ability and increase the need for social benefits such as sick leave compensation or disability pensions [2, 8,9,10].
Lower education level and income are associated with not returning to work after breast cancer either due to sick leave, unemployment, or other circumstances [11]. This has even been seen in studies conducted in welfare systems with universal healthcare access and a high level of social security [2, 3, 5, 12, 13]. Studies document a higher risk of both health-related benefits (e.g., sick leave) and labor market-related benefits (e.g., unemployment benefit) in people with low socioeconomic position [2, 3, 12, 13], but without presenting the total social benefit use in the populations. Two studies evaluated the full extent of social benefit use in women with breast cancer, but one did not account for socioeconomic position [5]. The other study only examined the influence of socioeconomic position on unemployment [3]. Furthermore, many studies included women with metastatic breast cancer, despite the poor prognosis, which is likely to increase social benefit use considerably [2, 3, 5, 14]. Moreover, social support from spouse or partner may be an important factor to regain or maintain the ability to work after breast cancer.
We therefore conducted a nationwide, population-based cohort study of premenopausal women diagnosed with stage I-III breast cancer in Denmark to investigate the total pattern of social benefit use before, during, and after diagnosis, and evaluated the impact of the social characteristics education and cohabitation.
Methods
Study design and setting
This cohort study was conducted in Denmark. Danish residents have uniform access to tax-funded health care and are safeguarded economically by the government in case of workforce detachment, sickness, or social issues limiting their labor market contribution [15, 16]. Several programs are implemented to help people return to work including vocational rehabilitation programs, job search assistance, counselling, and guidance. Upon free access to education, students aged ≥ 18 years receive a government-funded student grant each month (the State Education Grant). All social benefit payouts are recorded on a weekly basis and are linkable to other Danish administrative or health registries through a unique personal identifier assigned to all Danish residents upon birth or immigration [17].
Study population
We nested our cohort in the ProBe CaRe (Predictors of Breast Cancer Recurrence) cohort [18]. The ProBe Care cohort (n = 5959) is derived from a nationwide population of premenopausal women diagnosed with stage I-III primary breast cancer in Denmark during 2002–2011, and registered in the Danish Breast Cancer Group (DBCG) clinical database. Since 1977, the DBCG database has recorded all women under 70 years diagnosed with early-stage breast cancer in Denmark [19, 20]. Menopausal status at diagnosis was collected from the DBCG clinical database, but to minimize the risk of misclassification, we restricted our study population to women aged 18–55 years at date of surgery. The ProBe CaRe cohort comprised women who had estrogen receptor (ER)-positive breast cancer who initiated tamoxifen therapy, as well as women with ER-negative breast cancer who did undergo endocrine therapy [18]. For this study, we also restricted to all women who received at least one cycle of chemotherapy ensuring representation of those on guideline treatment regimens. We excluded women who had immigrated to Denmark less than 1 year prior to their breast cancer diagnosis, defined as the date of surgery.
Education and cohabitation
We ascertained data on the highest achieved level of education at the date of breast cancer diagnosis from the Danish Population’s Education Registry [21]. In accordance with the International Standard Classification of Education 2011 (ISCED 2011) [22], we categorized education level into short (ISCED 0–2), intermediate (ISCED 3–4), and long education (ISCED 5–8). Based on information from the Danish Civil Registration System [17], we categorized women as living alone or as cohabiting if they were married, in a registered partnership or living with a partner in accordance with criteria listed in Supplemental Table S1.
Social benefits
We obtained records of social benefit payments from the Danish Register for Evaluation of Marginalization (DREAM) from 1 January 2001 to 31 January 2021. The DREAM registry contains validated data on payments of sick leave compensation (long-term), unemployment benefits (part or full time), and other health and social benefits, registered weekly, since mid-1991 [23, 24].
We categorized social benefits into the following groups: self-supporting, unemployment, sick leave, disability pension, flexi job, other health-related benefits, other labor market-related benefits, and a censored group, which included women no longer expected to be part of the workforce due to retirement, recurrence, or other malignancies (Table 1). We considered people as self-supporting if they had no registered benefit in DREAM [25], or if they received the State Educational Grant [26]. Where women received maternity leave benefits during follow-up, we recoded these weeks into the category prior to the maternity leave. Additional details are included in Supplemental Table S3.
Sick leave registered in DREAM captures instances of long-term sick leave, recorded from the first day of illness until the end of the leave. Notably, short-term sick leave episodes, lasting less than 14–30 days (with the specific duration dependent on the calendar year, as outlined in Supplemental Table S4), are not included in the registry.
In Denmark, disability pensions are awarded to people with a permanent, substantial reduced work ability [27]. People with reduced work ability may be entitled to flexi jobs if they do not qualify for disability pensions. Flexi jobs are schemes where those employed have reduced working hours, to accommodate their work ability. The employer is entitled to a partial wage subsidy [28].
Covariates
From the DBCG clinical database [18], we collected information on age at diagnosis, date of surgery, ER status, HER2 status, grade (for ductal or lobular tumors) and number of positive lymph nodes, and tumor size to assign TNM (Tumor Node Metastasis) stage [29]. We collected information on type of surgery (mastectomy or lumpectomy including intention to treat radiation therapy) and chemotherapy (at least one cycle received), and dates of new primary cancers and breast cancer recurrences, adhering to DBCG’s definition as loco-regional, distant, or contralateral breast cancer [30]. From the Danish National Patient Registry, we collected information on comorbidities [31]. We summarized the number of comorbidities (except breast cancer) using the Charlson Comorbidity Index (Supplemental Table S1) [32]. We also collected dates of emigration and death from Statistics Denmark.
Statistical analyses
We described the study cohort using standard descriptive statistics. We graphically illustrated weekly proportions of receipt of social benefits from 1 year before breast cancer diagnosis and up to 10 years after. Women were censored—and hence excluded from the denominator—at date of retirement, breast cancer recurrence, new primary cancers, emigration, or death. We calculated absolute differences (percentage points, pp) in social benefit use 1 year pre-diagnosis and 10 years post-diagnosis to evaluate the influence of breast cancer. In addition, we stratified analyses by cohabitation and education status to examine social gradients. Further, we illustrated social benefit trajectories via a Sankey diagram using the same social benefit groups and an additional group extracting retirements from the censored group. All statistical analyses were conducted using SAS 9.4 (SAS Institute, Cary, NC).
Additional analyses
We repeated all the above analyses without censoring on recurrence and new primary cancers, to encompass the total social benefit use related to breast cancer and subsequent cancers.
Results
In total, 5375 women in the ProBeCaRe cohort were treated with at least one cycle of chemotherapy and aged 18–55 years. After excluding 30 women due to immigration to Denmark less than 1 year before date of breast cancer diagnosis, the study cohort included 5345 women. Cohort characteristics are presented in Table 2. Most of the breast cancers were stage II (55.0%), ER + (77.1%), HER2 − (59.3%), and among patients with ductal or lobular carcinoma, 44.5% were grade 2.
Overall social benefit use
The impact of breast cancer diagnosis on social benefit use was evident from a few weeks before diagnosis with a pronounced drop in self-supportiveness and an equivalent increase in sick leave at diagnosis (Fig. 1 and Table 3). One year after, half of the women were self-supporting, increasing to 68.1% after 2 years and remaining stable thereafter. In the week of diagnosis, 73.0% of women were on sick leave, which increased slightly in the first 6 months after diagnosis—the period when the women were undergoing chemotherapy, and dropped steadily afterwards reaching the pre-diagnostic level. Pre-diagnosis, 4.5% received a disability pension and 1.6% had flexi jobs. These proportions increased during follow-up to 13.0% and 10.5% at 10 years post-diagnosis, amounting to a 9 pp increase in both types of benefits. The proportion of unemployment decreased from 5.5% before diagnosis to 2.0%, 10 years after diagnosis (− 4 pp).
As seen from Fig. 2, among those who were self-supporting before diagnosis, 54.3% maintained their self-supportiveness, 3.5% retired, 3.4% were granted disability pensions, and 6.3% had flexi jobs 10 years after their diagnosis. A total of 20.6% of the self-supporting women were censored due to immigration, new primary cancers, breast cancer recurrence, or death. Among those unemployed before diagnosis, 33.1% were self-supporting 10 years after diagnosis, and 10.2% and 11.3% had disability pensions and flexi jobs, respectively. One-quarter of those on sick leave before diagnosis received disability pensions 10 years after. All proportions related to Fig. 2 are available in Supplemental Table S5.
Cohabitation
Among women living alone, 73.1% were self-supporting 1 year before diagnosis, 7.8% were on disability pensions, 2.5% had flexi jobs, 4.3% were on sick leave, and 6.1% were unemployed (Fig. 3 and Table 3). Among cohabiting women, these proportions were 84.1%, 3.6%, 1.4%, 3.4%, and 5.4%, respectively.
In the week of diagnosis, the proportion of those self-supporting dropped to 17.0% and 14.7% in cohabiting women and in women living alone, respectively. Two years after, 70.8% and 57.7%, respectively, were self-supporting, which was stable thereafter. At 10 years, 19.9% were on disability pensions and 12.2% in flexi jobs among women living alone. In cohabiting women, this was 11.3% and 10.1%. The absolute increase in the proportion on disability pensions was higher among those living alone, than in cohabiting women (12 pp vs. 8 pp).
Education level
The proportions of women who were self-supporting 1 year before breast cancer diagnosis were 66.6%, 81.3%, and 90.8% in those with short, medium, and long education, respectively (Fig. 4 and Table 3). These proportions dropped to 11.3%, 16.2%, and 19.7% in the week of breast cancer diagnosis. Two years after, the groups reached almost steady state of self-supportiveness of 53.5%, 66.0%, and 78.6%, respectively. The absolute differences indicated a social gradient in self-supportiveness according to education level as the decreases were larger among women with short or medium education (− 15 pp and − 14 pp) than in women with long education (− 10 pp).
We also found a negative education gradient in disability pension and flexi job with larger increases in the proportions among those with shorter education. The proportion of patients who received disability pensions increased from 12.1 to 26.4% (14 pp) in those with short education, from 4.1 to 12.8% (9 pp) in those with medium education, and from 0.8 to 6.0% (5 pp) in those with long education. Likewise, the proportion of women on flexi jobs increased from 2.8 to 13.5% (11 pp) in those with short education, from 1.8 to 12.2% (10 pp) in those with medium education, and from 0.9 to 6.9% (6 pp) in those with long education. The proportion of women on sick leave and unemployment were similar across education levels.
Results of additional analyses
The proportions found in the analyses including social benefits granted after a recurrence or a new primary cancer during follow-up were similar to those from the main analyses (Supplemental Figure S1 and Table S6).
Discussion
In this nationwide, population-based cohort of premenopausal women, we observed distinct social inequality in work participation and social benefit use after breast cancer. Compared with cohabiting women, disability pensions were more frequent in women living alone, and those with short education were more likely to be granted disability pensions and flexi jobs after their breast cancer than women with higher education.
In the USA, 27–40% of those employed at diagnosis were unemployed 3–5 years after breast cancer diagnosis [33,34,35]. One study found that women with low income had higher unemployment risk, but found no association with education [34]. Research in the USA suggests that health insurance status may affect work participation after breast cancer. A study including 708 women aged ≤ 45 years with early-stage breast cancer found that after 18 months, 56% and 16% were in full-time and part-time employment, respectively. Only 2.4% were disabled; 35% of the women were fearful of changing jobs due to the risk of losing their health insurance, and 26% experienced insurance-related problems post-diagnosis, e.g., increasing costs or insurance denial [36]. These issues may also be related to socioeconomic position. Other factors of importance in the USA include ethnicity and race, with lower rates of returning to work and higher proportions of sick leave in black women than in white women [37,38,39]. During the study period, immigrant/descendant women had markedly higher use of disability pensions in Denmark than non-immigrants/descendants, mainly due to mental health issues [40]. Still, fewer than 7% of our study population were immigrants or descendants, precluding any further analyses of social benefits according to ethnicity.
Our observed education gradient in self-supportiveness aligns with a study by Heinesen et al. [14] on Danish women with breast cancer diagnosed during 2000–2004. They found that the probability of losing employment increased by 9 pp among women with short education and by 5 pp among those with long education [14]. Heinesen et al. may have underestimated the education gradient as they excluded women who permanently left the workforce before breast cancer, died, or had a subsequent cancer diagnosis within 3 years of breast cancer diagnosis, which is more prevalent in women with short education [41]. Still, job type (blue vs. white-collar) explained some of the gradient; blue-collar workers are more likely to have short education level and physically demanding jobs.
Our observed drop in unemployment after breast cancer diagnosis echoes findings from a Dutch study [5]. Research suggests that unemployed people are more likely to leave the workforce permanently after cancer [14]. However, we found that one-third of the unemployed women became self-supporting, though some entered flexi jobs or disability pensions.
A Swedish study by Kvillemo et al. [42] reported that 34.7% of breast cancer survivors were on sick leave 2 years after diagnosis, which was considerably higher than in our study (11.3%). They found no changes in the proportion on disability pensions. Yet, Kvillemo and colleagues captured short-term sick leave (12.1%), which may explain some of the differences as short-term sick leave is not captured in DREAM. Still, diverse social policies across countries may also account for the observed differences. In Sweden, disability pensions can be part-time granted alongside sick leave [42], somewhat similar to the flexi job scheme in Denmark.
In Denmark, disability pensions and the flexi job schemes are reserved for those deemed unable to return to the work force, or with substantially reduced work ability. Our findings may therefore indicate debilitating breast cancer sequelae affecting the ability to work in women with low socioeconomic position and women living alone. This inequality is likely attributable to a complex interplay of various factors. Compared with people with long education, people with short education are more than twice as likely to have comorbidities [43]. Comorbidities are associated with increased risk of adverse events after cancer, which may impede a return to work after cancer. Further, a study by Dalton et al. [44] among 13,059 cancer survivors in Denmark found that women with breast cancer were as likely to be referred to rehabilitation after cancer regardless of their education level. However, those with long education were more likely to attend than those with medium or short education [44]. We note that Dalton et al. did not find any differences in referral to rehabilitation programs or attendance by cohabitation. Cohabiting women may have greater social support during diagnosis and treatment. Accordingly, these women may be more likely to maintain or regain their work ability, than women living alone.
Strengths and limitations
The strengths of this study include the detailed description of social benefit use in breast cancer survivors over an 11-year period, and the nationwide administrative and health care registries with complete follow-up. Registration of information on social benefits in DREAM has high validity compared with self-reported and employer-reported data [23, 24]. In fact, some benefits may be most valid when collected in the registries, as these go directly to the employer and not the individual [24]. Some women categorized as self-supporting may not have been working. Instead, these women may have been supported by their spouse or savings—a situation that might be more likely in cohabiting women and those with long education. However, the definition of self-supportiveness has been validated against self-report with a positive predictive value of 98% [24].
This study also has some limitations. Social security benefit policies continuously change, impacting the prevalence of specific benefits over time. Due to a change in the Disability Pension Act in 2013 tightening the criteria (Supplemental Table S4), contemporary cancer survivors may have a lower prevalence of disability pensions and higher prevalence of flexi jobs if diagnosed at a young age. Moreover, flexi jobs became temporary, and how this affects contemporary breast cancer survivors is yet unknown. Nonetheless, inequality in work ability after breast cancer may not change with these legislations. We note that our pre- and post-diagnostic comparison is somewhat compromised due to a decreasing denominator over time, especially in women living alone and/or those with shorter education as the rates of breast cancer recurrence and mortality are higher in these groups [41]. However, the inequality was similar when including women with recurrences in the analyses. Directly comparing our results to the general population would provide valuable context and enhance the external validity of our study, allowing us to better understand the relative uptake of social benefits. Unfortunately, we did not have access to a general population cohort in the current study.
Perspectives
Our long follow-up and detailed description of social benefit use patterns may inform timing of intervention strategies and target populations among breast cancer survivors. A recent systematic review found a lack of evidence on effective interventions to support work participation after cancer among unemployed or work-disabled cancer survivors. Most studies pointed towards multicomponent interventions (e.g., job search assistance and vocational training) like the standard social efforts provided in Denmark [45]. Literature also suggests that job type and employer’s willingness to offer flexible working schedules (as distinct from flexi jobs) can support a return to work after illness [46, 47]. A flexible work schedule could include working or staying home when mentally or physically challenged. The positive effect of being offered flexible working schedules has mainly been seen in cancer survivors with manual jobs and in people with short education [48]. This may be because people with long education are less likely to have manual jobs and already possess jobs with a high level of flexibility [48].
Conclusions
Despite Denmark’s uniform access to healthcare and guaranteed income security, we found a negative education gradient in disability pensions and flexi jobs among breast cancer survivors. Moreover, women living alone were more likely to receive disability pensions. These findings suggest that the likelihood of losing the ability to work after breast cancer was inversely associated with education level and cohabitation status. As such, women with shorter education and women living alone may benefit from programs aimed at supporting work force participation after breast cancer. Mechanistic insights may be needed to design such programs.
Data availability
The data used for the current study derive from nationwide, population-based administrative and medical registries, linked anonymously using the Civil registration a personalized-identifier. The data are available from Statistics Denmark, DBCG, and the corresponding author. Restrictions apply to the availability of these data, which were used under license for this study. Data are available from the authors upon reasonable request with the permission of Statistics Denmark, DBCG, The Danish Health Authorities, The Danish Data Protection Agency, and The Central Jutland Region Committee on Health Research Ethics.
References
Heer E, Harper A, Escandor N, Sung H, McCormack V, Fidler-Benaoudia MM. Global burden and trends in premenopausal and postmenopausal breast cancer: a population-based study. Lancet Glob Health. 2020;8:e1027–37.
Kvillemo P, Mittendorfer-Rutz E, Bränström R, Nilsson K, Alexanderson K. Sickness absence and disability pension after breast cancer diagnosis: a 5-year nationwide cohort study. J Clin Oncol Off J Am Soc Clin Oncol. 2017;35:2044–52.
Carlsen K, Ewertz M, Dalton SO, Badsberg JH, Osler M. Unemployment among breast cancer survivors. Scand J Public Health. 2014;42:319–28.
Drolet M, Maunsell E, Mondor M, Brisson C, Brisson J, Mâsse B, et al. Work absence after breast cancer diagnosis: a population-based study. CMAJ Can Med Assoc J J Assoc Medicale Can. 2005;173:765–71.
Paalman CH, Van Leeuwen FE, Aaronson NK, De Boer AGEM, Van De Poll-Franse L, Oldenburg HSA, et al. Employment and social benefits up to 10 years after breast cancer diagnosis: a population-based study. Br J Cancer. 2016;114:81–7.
Schmidt ME, Scherer S, Wiskemann J, Steindorf K. Return to work after breast cancer: the role of treatment-related side effects and potential impact on quality of life. Eur J Cancer Care (Engl). 2019;28: e13051.
Thomson RM, Igelström E, Purba AK, Shimonovich M, Thomson H, McCartney G, et al. How do income changes impact on mental health and wellbeing for working-age adults? A systematic review and meta-analysis. Lancet Public Health. 2022;7:e515–28.
Plym A, Johansson ALV, Bower H, Wennstig A-K, Fredriksson I, Ahlgren J, et al. Impact of chemotherapy, radiotherapy, and endocrine therapy on sick leave in women with early-stage breast cancer during a 5-year period: a population-based cohort study. Breast Cancer Res Treat. 2020;182:699–707.
Petersson L-M, Vaez M, Nilsson MI, Saboonchi F, Alexanderson K, Olsson M, et al. Sickness absence following breast cancer surgery: a two-year follow-up cohort study. Scand J Caring Sci. 2018;32:715–24.
Heiman J, Pavia J, Bock D, Haglind E, Olofsson BR. Sick leave and predictive factors for sick leave at 12 months after breast cancer surgery in the randomized controlled physical activity trial (PhysSURG-B). Surg J R Coll Surg Edinb Irel. 2023;21:e229–37.
Wang L, Hong BY, Kennedy SA, Chang Y, Hong CJ, Craigie S, et al. Predictors of unemployment after breast cancer surgery: a systematic review and meta-analysis of observational studies. J Clin Oncol. 2018;36:1868–79.
Chen L, Alexanderson KAE. Trajectories of sickness absence and disability pension in the 2 years before and 3 years after breast cancer diagnosis: a Swedish longitudinal population-based cohort study. Cancer. 2020;126:2883–91.
Drolet M, Maunsell E, Brisson J, Brisson C, Mâsse B, Deschênes L. Not working 3 years after breast cancer: predictors in a population-based study. J Clin Oncol. 2005;23:8305–12.
Heinesen E, Kolodziejczyk C. Effects of breast and colorectal cancer on labour market outcomes-average effects and educational gradients. J Health Econ. 2013;32:1028–42.
Andersen TM, Svarer M. Flexicurity—labour market performance in Denmark*. CESifo Econ Stud. 2007;53:389–429.
Schmidt M, Schmidt SAJ, Adelborg K, Sundbøll J, Laugesen K, Ehrenstein V, et al. The Danish health care system and epidemiological research: from health care contacts to database records. Clin Epidemiol. 2019;11:563–91.
Schmidt M, Pedersen L, Sørensen HT. The Danish Civil Registration System as a tool in epidemiology. Eur J Epidemiol. 2014;29:541–9.
Collin LJ, Cronin-Fenton DP, Ahern TP, et al. Cohort Profile: the predictors of breast cancer recurrence (ProBe CaRE) premenopausal breast cancer cohort study in denmark. BMJ Open. 2018;8(7):e021805. https://doi.org/10.1136/bmjopen-2018-021805
Jensen M-B, Laenkholm A-V, Offersen BV, Christiansen P, Kroman N, Mouridsen HT, et al. The clinical database and implementation of treatment guidelines by the Danish Breast Cancer Cooperative Group in 2007–2016. Acta Oncol. 2018;57:13–8.
Christiansen P, Ejlertsen B, Jensen M-B, Mouridsen H. Danish Breast Cancer Cooperative Group. Clin Epidemiol. 2016;8:445–9.
Jensen VM, Rasmussen AW. Danish Education Registers. Scand J Public Health. 2011;39(7 Suppl):91–4.
International Standard Classification of Education: ISCED 2011. UNESCO Institute for Statistics; 2012.
Stapelfeldt CM, Jensen C, Andersen NT, Fleten N, Nielsen CV. Validation of sick leave measures: self-reported sick leave and sickness benefit data from a Danish national register compared to multiple workplace-registered sick leave spells in a Danish municipality. BMC Public Health. 2012;12:661.
Hjollund NH, Larsen FB, Andersen JH. Register-based follow-up of social benefits and other transfer payments: accuracy and degree of completeness in a Danish interdepartmental administrative database compared with a population-based survey. Scand J Public Health. 2007;35:497–502.
Biering K, Hjøllund NH, Lund T. Methods in measuring return to work: a comparison of measures of return to work following treatment of coronary heart disease. J Occup Rehabil. 2013;23:400–5.
State Educational Grant and Loan Scheme (SU and SU-lån) - su.dk. https://www.su.dk/english/state-educational-grant-and-loan-scheme-su/. Accessed 24 Apr 2023.
Denmark—employment, social affairs & inclusion—European Commission. https://ec.europa.eu/social/main.jsp?catId=1107&langId=en&intPageId=4493. Accessed 16 Mar 2023.
Jensen V, Lundager B, Christensen AL, Fonager K. Unemployment under the flex job scheme increases the risk of permanent social security benefits. Dan Med J. 2014;61:A4804.
Amin MB, American Joint Committee on Cancer, American Cancer Society, eds. AJCC Cancer Staging Manual. Eight edition. American Joint Committee on Cancer, Springer; 2017.
Møller S, Jensen M-B, Ejlertsen B, Bjerre KD, Larsen M, Hansen HB, et al. The clinical database and the treatment guidelines of the Danish Breast Cancer Cooperative Group (DBCG); its 30-years experience and future promise. Acta Oncol Stockh Swed. 2008;47:506–24.
Schmidt M, Schmidt SAJ, Sandegaard JL, Ehrenstein V, Pedersen L, Sørensen HT. The Danish National Patient Registry: a review of content, data quality, and research potential. Clin Epidemiol. 2015;7:449–90.
Charlson ME, Pompei P, Ales KL, MacKenzie CR. A new method of classifying prognostic comorbidity in longitudinal studies: development and validation. J Chronic Dis. 1987;40:373–83.
Jagsi R, Hawley ST, Abrahamse P, Li Y, Janz NK, Griggs JJ, et al. Impact of adjuvant chemotherapy on long-term employment of survivors of early-stage breast cancer. Cancer. 2014;120:1854–62.
Blinder V, Patil S, Eberle C, Griggs J, Maly RC. Early predictors of not returning to work in low-income breast cancer survivors: a 5-year longitudinal study. Breast Cancer Res Treat. 2013;140:407–16.
Blinder VS, Murphy MM, Vahdat LT, Gold HT, de Melo-Martin I, Hayes MK, et al. Employment after a breast cancer diagnosis: a qualitative study of ethnically diverse urban women. J Community Health. 2012;37:763–72.
Naughton MJ, Beverly Hery CM, Janse SA, Naftalis EZ, Paskett ED, Van Zee KJ. Prevalence and correlates of job and insurance problems among young breast cancer survivors within 18 months of diagnosis. BMC Cancer. 2020;20:432.
Islam T, Dahlui M, Majid HA, Nahar AM, Mohd Taib NA, Su TT. Factors associated with return to work of breast cancer survivors: a systematic review. BMC Public Health. 2014;14:S8.
Chaker L, Falla A, van der Lee SJ, Muka T, Imo D, Jaspers L, et al. The global impact of non-communicable diseases on macro-economic productivity: a systematic review. Eur J Epidemiol. 2015;30:357–95.
Blinder VS, Patil S, Thind A, Diamant A, Hudis CA, Basch E, et al. Return to work in low-income Latina and non-Latina white breast cancer survivors: a 3-year longitudinal study. Cancer. 2012;118:1664–74.
Ankestyrelsen. Topic of Granting Disability Pensions to Refugees and Other Non-Western Immigrants [In Danish: Tema Om Tilkendelser Af Førtidspension Til Flygtninge Og Øvrige Ikke-Vestlige Indvandrere). Ankestyrelsen; 2012.
Hjorth CF, Damkier P, Ejlertsen B, Lash T, Sørensen HT, Cronin-Fenton D. Socioeconomic position and prognosis in premenopausal breast cancer: a population-based cohort study in Denmark. BMC Med. 2021;19(1). https://doi.org/10.1186/s12916-021-02108-z.
Kvillemo PK, Chen L, Bottai M, Frumento P, Almondo G, Mittendorfer-Rutz E, et al. Sickness absence and disability pension among women with breast cancer: a population-based cohort study from Sweden. BMC Public Health. 2021;21:697.
Schramm S, Møller SP, Tolstrup JS, Laursen B. Effects of individual and parental educational levels on multimorbidity classes: a register-based longitudinal study in a Danish population. BMJ Open. 2022;12: e053274.
Dalton SO, Olsen MH, Moustsen IR, Andersen CW, Vibe-Petersen J, Johansen C. Socioeconomic position, referral and attendance to rehabilitation after a cancer diagnosis: a population-based study in Copenhagen, Denmark 2010–2015. Acta Oncol. 2019;58:730–6.
van Ommen F, Coenen P, Malekzadeh A, de Boer AGEM, Greidanus MA, Duijts SFA. Interventions for work participation of unemployed or work-disabled cancer survivors: a systematic review. Acta Oncol. 2023;0(0):1–12. https://doi.org/10.1080/0284186X.2023.2187261.
Kollerup A, Ladenburg J. Willingness to pay for accommodating job attributes when returning to work after cancer treatment: a discrete choice experiment with Danish breast cancer survivors. Labour. 2021;35:378–411.
Alleaume C, Paraponaris A, Bendiane M-K, Peretti-Watel P, Bouhnik A-D. The positive effect of workplace accommodations on the continued employment of cancer survivors five years after diagnosis. Support Care Cancer Off J Multinatl Assoc Support Care Cancer. 2020;28:4435–43.
Kollerup A, Ladenburg J, Heinesen E, Kolodziejczyk C. The importance of workplace accommodation for cancer survivors—the role of flexible work schedules and psychological help in returning to work. Econ Hum Biol. 2021;43: 101057.
Funding
Open access funding provided by Aarhus Universitet This project received funding from the Danish Cancer Society (R167-A11045-17-S2, R327-A19070), the Platform for Inequality Research at Aarhus University (Pireau), and the Novo Nordisk Foundation (NNF20OC0065928, NNF19OC0058710). The funders had no role in the design, conduct, or publication of the present study.
Author information
Authors and Affiliations
Contributions
C.F.H.: conceptualization, data curation, formal analysis, methodology, project administration, investigation, visualization, writing—original draft. J.A.S.: methodology, writing—review and editing. D.K.F.: data curation, software, formal analysis, visualization, writing—review and editing. D.C.: methodology, funding acquisition, supervision, writing—review and editing.
Corresponding author
Ethics declarations
Ethics approval
The study was approved by The Danish Clinical Quality Program, National Clinical Registries (RKKP), the Danish Breast Cancer Group [DBCG-2023–02-01a], and by the Danish Data Protection Agency (record number 2016–051-000001/994).
Consent to participate
The use of register-based data for scientific studies in Denmark requires no consent from the participants.
Conflict of interest
The authors declare no competing interests.
Additional information
Publisher's Note
Springer Nature remains neutral with regard to jurisdictional claims in published maps and institutional affiliations.
Supplementary Information
Below is the link to the electronic supplementary material.
Rights and permissions
Open Access This article is licensed under a Creative Commons Attribution 4.0 International License, which permits use, sharing, adaptation, distribution and reproduction in any medium or format, as long as you give appropriate credit to the original author(s) and the source, provide a link to the Creative Commons licence, and indicate if changes were made. The images or other third party material in this article are included in the article's Creative Commons licence, unless indicated otherwise in a credit line to the material. If material is not included in the article's Creative Commons licence and your intended use is not permitted by statutory regulation or exceeds the permitted use, you will need to obtain permission directly from the copyright holder. To view a copy of this licence, visit http://creativecommons.org/licenses/by/4.0/.
About this article
Cite this article
Hjorth, C.F., Schmidt, J.A., Farkas, D.K. et al. Social characteristics and social benefit use among premenopausal breast cancer survivors in Denmark: a population-based cohort study. J Cancer Surviv (2024). https://doi.org/10.1007/s11764-024-01598-z
Received:
Accepted:
Published:
DOI: https://doi.org/10.1007/s11764-024-01598-z